iView Therapeutics
Developer of topical drugs designed for applications in ophthalmology, dermatology, and otolaryngology. The company develops drugs including long-acting povidone-iodine ophthalmic formulations for the...
Valuation
$107.4M
Latest known
Share Price
N/A
Total Raised
$39.2M
Last Round
N/A